Paul Conyngham used AI to pinpoint the mutations in his dog Rose's tumor — and used the data to have a treatment made just ...

Paul Conyngham's 8-year-old rescue dog had a fatal skin cancer. He turned to AI to see if he could create a personalized anti ...

When his beloved dog was given months to live, an Australian man harnessed the power of machine learning and mRNA technology ...

One dog, one vaccine, one data point. The story of Rosie is fascinating – but it is not yet evidence that AI can beat cancer.

A tech entrepreneur's dedication to helping his dog fight cancer is potentially opening doors for better treatments and ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...

The next generation RNA therapeutics market presents significant growth opportunities, driven by the development of over 100 RNA therapies and vaccines, advancing research, and robust investment ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, delivering top candidates in ...

As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.